Skip to main content
xMedica

Search

7 studies match these filters. Showing 1–7 of 7 studies

Search results
Registration numberStudyStatusPhaseEnrolmentSites / countriesStart yearLast updatedActions
NCT06956014Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy

The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were un…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 43 sites in total · contact listed

RecruitingPhase 3810target43 / 12026Nov 19, 2026
NCT05922878Study of ALTO-300 in MDD

The purpose of this study is to determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 75 sites in total

RecruitingPhase 2325target75 / 12023Oct 26, 2026
NCT06547489Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

The goal of this clinical trial is to learn if zelquistinel works to treat depression in adults. It will also learn about the safety of zelquistinel. The main questions it aims to answer are: Does zelquistinel reduce depression scores in participants compared to participants who take a placebo (a l…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 34 sites in total

RecruitingPhase 2164target34 / 12025Aug 3, 2026
NCT06847321Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental decline in the last year and who have P. gingivalis (Pg) infection. P. gingivalis infection has been linked to the development of dementia. LHP588 is designed to target the P.…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 39 sites in total · contact listed

RecruitingPhase 2300target39 / 12025Oct 7, 2026
NCT07326709A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

The purpose is to assess safety and tolerability of votoplam and to determine whether votoplam slows disease progression in patients with early symptomatic Huntington's disease (HD) compared to the control arm. HTT227 - current compound code (former code is PTC518 from PTC Therapeutics), HTT227 is…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 117 sites in total · contact listed

RecruitingPhase 3770target117 / 272026Sep 22, 2026
NCT07609108Pridopidine Phase 3 Study in Huntington's Disease

The goal of this clinical trial is to learn if pridopidine can slow the clinical decline of Huntington's Disease (HD) in adult participants. It will also inform about the safety of pridopidine. The main questions the study aims to answer are: Does pridopidine slow the overall worsening of HD over…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 66 sites in total · contact listed

RecruitingPhase 3400target66 / 122026Nov 19, 2026
NCT01574053Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 183 sites in total · contact listed

RecruitingNot verified since Feb 1, 202435,000target183 / 202012Feb 28, 2024

Filters

Clear all filters